Parker Waichman LLP

Acellular Dermal Matrix Lawsuits

Acellular Dermal Matrix Lawsuits for Breast Reconstruction Failure, Breast Implant Explantation, Necrosis, Seroma, and Other Major Complications. WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) released an important FDA Safety Communication concerning Acellular Dermal Matrix (ADM) products used in implant-based breast reconstruction surgery that appear to have a higher probability for issues or […]

Acellular Dermal Matrix Lawsuits for Breast Reconstruction Failure, Breast Implant Explantation, Necrosis, Seroma, and Other Major Complications.

Acellular dermal matrix lawsuits

Breast implant explantation

WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) released an important FDA Safety Communication concerning Acellular Dermal Matrix (ADM) products used in implant-based breast reconstruction surgery that appear to have a higher probability for issues or complications. The FDA is warning surgeons, health care providers, and patients of its recent analysis concerning Acellular Dermal Matrix (ADM) products and is requesting immediate reporting of all adverse events to help the agency better understand the risks of ADM products.

Women who are undergoing reconstructive breast surgery after a mastectomy are typically given several surgical options. In breast reconstruction procedures using implants, the surgeon may choose to use only breast implants or use breast implants with ADM. Acellular Dermal Matrix is a surgical mesh that is developed from human skin or animal skin. The use of ADM in breast reconstruction surgery has not been cleared or approved by the FDA.

Which Brands of Acellular Dermal Matrix Mesh (ADM) Are Being Investigated for Potential Compensation?

Did You or a Loved One Suffer One or More of These Complications Caused by FlexHD or Allomax (Becton Dickinson/Bard)?

  • Infection,
  • Seroma,
  • Mastectomy flap/skin necrosis,
  • Cellulitis,
  • Implant explantation (implant or additional breast tissue removal), and/or
  • Reconstructive failure.

Did you or a loved one suffer harm due to Allomax or FlexHD? Parker Waichman LLP helps victims and families receive justice and full monetary compensation for harm caused by defective Acellular Dermal Matrix (ADM) products. For a free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).

The FDA Has Provided the Following Recommendations and Guidance for Breast Reconstruction Patients and Caregivers

Prior to surgery, patients undergoing breast reconstruction surgery should discuss the risks, benefits, and potential complications associated with implant-based breast reconstruction with or without ADM. If the surgeon is suggesting that ADM should be used, speaking with that surgeon  about the type of ADM to be used during the surgical procedure is essential.

Although ADM is used in other types of reconstructive surgical procedures, the FDA has not approved or cleared the use of ADM for use in breast reconstruction procedures.

If you or a family member have had breast reconstruction surgery with ADM and are experiencing complications, side effects, infections, seroma, cellulitis, necrosis, reconstructive breast failure, need for reoperation, or any other problem, the FDA encourages you to report these medical conditions and complaints to MedWatch, the FDA’s Safety Information and Adverse Event Reporting program.

  • Infection,
  • Seroma,
  • Mastectomy flap/skin necrosis,
  • Cellulitis,
  • Implant explantation (implant or additional breast tissue removal), and/or
  • Reconstructive failure.

Health care providers should be aware that the “FDA has not cleared or approved any ADM products for use in implant-based reconstruction surgery.” Moreover, recent data collected and examined by the FDA and published literature suggest that some ADM products may be connected with higher risk profiles than others.

Also, the FDA does not currently recommend the removal of implanted ADM or reoperation as a preventive measure at this time.

Acellular Dermal Matrix (ADM) Device Description

Acellular Dermal Matrix (ADM) is a surgical mesh that is developed from human skin (FlexHD, AlloMax, AlloDerm) or animal skin (SurgiMend). The product is manufactured by removing cells and leaving the support structure in place. According to the FDA, ADM products vary significantly in their source material, biomechanical properties, processing, level of sterility, final product state, thickness, and preparation methods before surgical application.

ADM Risk Profile in Implant-based Breast Reconstruction Operations

For the past several years, the use of ADM “off-label” in implant-based breast reconstruction treatment has increased. The use of ADM is now very common, although the FDA has not approved or cleared ADM for use in breast reconstruction procedures.

The FDA has recently completed an overall analysis of patient-level data collected from real-world ADM usage in implant-based breast reconstruction. The data suggests that two particular ADMs, FlexHD, and Allomax, may have a higher risk of complications than other ADM products.

The Mastectomy Reconstruction Outcomes Consortium (MROC) study collected data from 11 medical centers, including nine academic hospitals located in the United States and Canada, that performed a high volume of breast reconstruction procedures. The purpose of the study was to assess the outcomes in patients who underwent implant-based breast reconstruction after a mastectomy. The study collected data on major post-surgical complications, including reoperation, explanation (implant removal), and infections. The FDA conducted an analysis based on this data, comparing the complication rates between the control group, those patients who never received ADM, and groups receiving one of the suspect ADM brands (FlexHD, AlloMax, SurgiMend, and AlloDerm.)  The FDA also analyzed and compared the complication rates between the various ADMs themselves.

The FDA’s review of the MROC study’s data revealed substantially higher “major complication” rates of explanation, reoperation, and infections in the groups of patients implanted with FlexHD and AlloMax brands of ADM within two years of the surgery when compared to groups of patients who received AlloDerm or SurgiMend ADM brands, or the control group that did not receive any ADM products. Moreover, the increase in complications connected with AlloMax or FlexHD was observed across multiple sites.

Physicians must be aware that real-world data suggests some ADM products could have higher risk profiles than others. Right now, the FDA is not recommending preventive reoperation and removal of any implanted ADM. The FDA also stated that it is not aware of any data that proves there is a link between ADM use and the development of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).

The root cause of the varying complication rates between the different brands of ADM is unknown. However, patients and health care providers are being put on notice of the  FDA’s findings and concerns.  They are being told to report adverse events to the FDA in hopes of better understand the risks associated with Allomax and FlexHD.

CONTACT PARKER WAICHMAN LLP FOR A FREE CASE REVIEW

Parker Waichman LLP helps victims and families receive justice and full monetary compensation for harm caused by the Allomax or FlexHD ADMs. Trust your case to our defective product injury attorneys.  For a free consultation, contact our law firm today by using our live chat or calling 1-800-YOUR-LAWYER (1-800-968-7529).

Acellular dermal matrix lawsuits
What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
I would like to give a special shout out to Jorge, Mary-Ann, and Julie for helping me out so much.
Altagracia Reyes
3 days ago
5 Star Reviews 150
Don't know where to begin, as I speak of ur honest n responsible worker Mrs. M.Josama if I had a law firm I would ask u to please except her resignation . She would have to work for my firm. One of a kind.
Ruth Rodriguez
4 years ago
5 Star Reviews 150
Positive: Professionalism
James Carr
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038